L. Iaccarino, A. Ghirardello, S. Bettio, M. Zen, M. Gatto et al., The clinical features, diagnosis and classification of dermatomyositis, Journal of Autoimmunity, vol.48, issue.49, pp.122-129, 2014.
DOI : 10.1016/j.jaut.2013.11.005

C. P. Myosites, Httpwwwem-Premiumcomdocelecu- Bordeauxfrdatatraitestmtm-49767 [Internet]. 16 févr, 2011.

M. Dalakas, Inflammatory Muscle Diseases, New England Journal of Medicine, vol.372, issue.18, pp.1734-1781, 2015.
DOI : 10.1056/NEJMra1402225

O. Benveniste, O. Dubourg, and S. Herson, Nouvelles classifications et??physiopathologie des??myopathies inflammatoires, La Revue de M??decine Interne, vol.28, issue.9, pp.603-615, 2007.
DOI : 10.1016/j.revmed.2007.03.004

A. Meyer, B. Lannes, J. Goetz, A. Echaniz-laguna, D. Lipsker et al., Les nouvelles myopathies inflammatoires, Revue du Rhumatisme, vol.84, issue.5, pp.392-402, 2017.
DOI : 10.1016/j.rhum.2017.01.013

M. Fujimoto, R. Watanabe, Y. Ishitsuka, and N. Okiyama, Recent advances in dermatomyositis-specific autoantibodies, Current Opinion in Rheumatology, vol.28, issue.6, pp.636-680, 2016.
DOI : 10.1097/BOR.0000000000000329

I. Targoff, G. Mamyrova, E. Trieu, O. Perurena, B. Koneru et al., A novel autoantibody to a 155-kd protein is associated with dermatomyositis, Arthritis & Rheumatism, vol.201, issue.11, pp.3682-3691, 2006.
DOI : 10.1097/00005792-199111000-00002

D. Fiorentino, K. Kuo, L. Chung, L. Zaba, S. Li et al., Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1?? antibodies in adults with dermatomyositis, Journal of the American Academy of Dermatology, vol.72, issue.3, pp.449-55, 2015.
DOI : 10.1016/j.jaad.2014.12.009

K. Fujikawa, A. Kawakami, K. Kaji, M. Fujimoto, S. Kawashiri et al., Association of distinct clinical subsets with myositis???specific autoantibodies towards anti???155/140???kDa polypeptides, anti???140???kDa polypeptides, and anti???aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single???centre, cross???sectional study, Scandinavian Journal of Rheumatology, vol.47, issue.4, pp.263-270, 2009.
DOI : 10.2169/internalmedicine.47.0639

A. Bohan and J. Peter, Polymyositis and Dermatomyositis, New England Journal of Medicine, vol.292, issue.7, pp.344-351, 1975.
DOI : 10.1056/NEJM197502132920706

M. Dalakas and R. Hohlfeld, Polymyositis and dermatomyositis, The Lancet, vol.362, issue.9388, pp.971-82, 2003.
DOI : 10.1016/S0140-6736(03)14368-1

J. Hoogendijk, A. Amato, B. Lecky, E. Choy, I. Lundberg et al., 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, Neuromuscul Disord NMD. mai, vol.14, issue.5, pp.10-12337, 2003.

H. Linklater, N. Pipitone, M. Rose, F. Norwood, R. Campbell et al., Classifying idiopathic inflammatory myopathies: comparing the performance of six existing criteria, Clin Exp Rheumatol. oct, vol.31, issue.5, pp.767-776, 2013.

M. Satoh, S. Tanaka, A. Ceribelli, S. Calise, and E. Chan, A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy, Clinical Reviews in Allergy & Immunology, vol.42, issue.Suppl, pp.1-19, 2017.
DOI : 10.1007/s12016-011-8286-7

A. Masiak, J. Kulczycka, Z. Czuszy?ska, and Z. Zdrojewski, Clinical characteristics of patients with anti-TIF1-?? antibodies, Reumatologia/Rheumatology, vol.1, issue.1, pp.14-22, 2016.
DOI : 10.5114/reum.2016.58756

K. Kaji, M. Fujimoto, M. Hasegawa, M. Kondo, Y. Saito et al., Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy, Rheumatology, vol.46, issue.1, pp.25-33, 2007.
DOI : 10.1093/rheumatology/kel161

K. Hoshino, Y. Muro, K. Sugiura, Y. Tomita, R. Nakashima et al., Anti-MDA5 and anti-TIF1-?? antibodies have clinical significance for patients with dermatomyositis, Rheumatology, vol.60, issue.9, pp.1726-1759, 2010.
DOI : 10.1002/art.24547

L. Bodoki, M. Nagy-vincze, Z. Griger, Z. Betteridge, L. Szöll?si et al., Four dermatomyositis-specific autoantibodies???anti-TIF1??, anti-NXP2, anti-SAE and anti-MDA5???in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort, Autoimmunity Reviews, vol.13, issue.12, pp.1211-1220, 2014.
DOI : 10.1016/j.autrev.2014.08.011

M. Fujimoto, Y. Hamaguchi, K. Kaji, T. Matsushita, Y. Ichimura et al., Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins, Arthritis & Rheumatism, vol.8, issue.Suppl, pp.513-535, 2012.
DOI : 10.1038/nri2413

URL : http://onlinelibrary.wiley.com/doi/10.1002/art.33403/pdf

X. Lu, H. Yang, X. Shu, F. Chen, Y. Zhang et al., Factors Predicting Malignancy in Patients with Polymyositis and Dermatomyostis: A Systematic Review and Meta-Analysis, PLoS ONE, vol.115, issue.5, p.94128, 2014.
DOI : 10.1371/journal.pone.0094128.s003

Z. Yang, F. Lin, B. Qin, Y. Liang, and R. Zhong, Polymyositis/dermatomyositis and Malignancy Risk: A Metaanalysis Study, The Journal of Rheumatology, vol.42, issue.2, pp.282-91, 2015.
DOI : 10.3899/jrheum.140566

A. Ghirardello, M. Rampudda, L. Ekholm, N. Bassi, E. Tarricone et al., Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay, Rheumatology, vol.65, issue.12, pp.2370-2374, 2010.
DOI : 10.1136/ard.2006.052191

I. Cavazzana, M. Fredi, A. Ceribelli, C. Mordenti, F. Ferrari et al., Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera, Journal of Immunological Methods, vol.433, pp.1-5, 2016.
DOI : 10.1016/j.jim.2016.02.017

M. Tampoia, A. Notarnicola, L. Abbracciavento, A. Fontana, M. Giannini et al., A New Immunodot Assay for Multiplex Detection of Autoantibodies in a Cohort of Italian Patients With Idiopathic Inflammatory Myopathies, Journal of Clinical Laboratory Analysis, vol.384, issue.6, pp.859-66, 2016.
DOI : 10.1016/j.jim.2012.07.019

C. Bundell, A. Rojana-udomsart, F. Mastaglia, P. Hollingsworth, and A. Mclean-tooke, Diagnostic performance of a commercial immunoblot assay for myositis antibody testing, Pathology, vol.48, issue.4, pp.363-369, 2016.
DOI : 10.1016/j.pathol.2016.03.012

A. Chevailler, . Bc, and F. Carrère, Dépistage des anticorps dirigés contre les antigènes nucléaires solubles. Rev Fr Lab, juill, issue.384, pp.59-70, 2006.

L. Zanardo, Difficultés d'interprétation des immunodots myosite : exemple d'une réaction croisée entre les anti-centromères A et la protéine TIF1gamma, 2017.

P. Venalis, S. Selickaja, K. Lundberg, R. Rugiene, and I. Lundberg, Anti-TIF1-gamma antibodies are not associated with other paraneoplastic rheumatic syndromes than dermatomyositis, Arthritis Care & Research, 2017.
DOI : 10.1002/acr.23325

S. Jouneau, B. Hervier, E. Jutant, O. Decaux, M. Kambouchner et al., Les manifestations pulmonaires du syndrome des antisynth??tases, Revue des Maladies Respiratoires, vol.32, issue.6, pp.618-646, 2015.
DOI : 10.1016/j.rmr.2014.07.013

URL : https://doi.org/10.1016/j.rmr.2014.07.013

I. Marie, S. Josse, O. Decaux, S. Dominique, E. Diot et al., Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome, Autoimmunity Reviews, vol.11, issue.10, pp.739-784, 2012.
DOI : 10.1016/j.autrev.2012.01.006

URL : https://hal.archives-ouvertes.fr/hal-00872923

B. Hervier and O. Benveniste, Phénotypes cliniques et pronostic du syndrome des antisynthétases. Httpwwwem-Premiumcomdocelecu- Bordeauxfrdatarevues02488663v35i7S0248866313006462 [Internet], Disponible sur, 2014.
DOI : 10.1016/j.revmed.2013.09.003

O. Benveniste, W. Stenzel, and Y. Allenbach, Advances in serological diagnostics of inflammatory myopathies, Current Opinion in Neurology, vol.29, issue.5, pp.662-73, 2016.
DOI : 10.1097/WCO.0000000000000376

O. Benveniste, L. Drouot, F. Jouen, J. Charuel, C. Bloch-queyrat et al., Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy, Arthritis & Rheumatism, vol.247, issue.7, pp.1961-71, 2011.
DOI : 10.1007/s004150050585

R. Aggarwal, C. Oddis, D. Goudeau, D. Koontz, Z. Qi et al., Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab, Rheumatology, vol.63, issue.6, pp.991-1000, 2016.
DOI : 10.1093/rheumatology/ket383

P. Biscay, M. Ralazamahaleo, E. Lazaro, C. Richez, J. Seneschal et al., Relevance assessment of requests for antineutrophil cytoplasmic antibodies detection: Retrospective study led in Bordeaux Hospital, France], Rev Med Interne. 6 juill, 2017.

D. Dimitri, Myopathies inflammatoires : diagnostic et classifications. Presse Médicale, juill, vol.38, pp.7-81141, 2009.
DOI : 10.1016/j.lpm.2009.01.013

A. Meyer, N. Meyer, M. Schaeffer, J. Gottenberg, B. Geny et al., Incidence and prevalence of inflammatory myopathies: a systematic review, Rheumatology, vol.54, issue.1, pp.50-63, 2015.
DOI : 10.1016/j.jaad.2005.10.041

L. Iaccarino, A. Ghirardello, S. Bettio, M. Zen, M. Gatto et al., The clinical features, diagnosis and classification of dermatomyositis, Journal of Autoimmunity, vol.48, issue.49, pp.122-129, 2014.
DOI : 10.1016/j.jaut.2013.11.005

M. Van-der-meulen, I. Bronner, J. Hoogendijk, H. Burger, W. Van-venrooij et al., Polymyositis, Neurology, vol.61, issue.3, pp.316-337, 2003.
DOI : 10.1212/WNL.61.3.316

A. Bohan and J. Peter, Polymyositis and Dermatomyositis, New England Journal of Medicine, vol.292, issue.7, pp.344-351, 1975.
DOI : 10.1056/NEJM197502132920706

K. Tanimoto, K. Nakano, S. Kano, S. Mori, H. Ueki et al., Classification criteria for polymyositis and dermatomyositis, J Rheumatol. avr, vol.22, issue.4, pp.668-74, 1995.

M. Dalakas and R. Hohlfeld, Polymyositis and dermatomyositis, The Lancet, vol.362, issue.9388, pp.971-82, 2003.
DOI : 10.1016/S0140-6736(03)14368-1

J. Hoogendijk, A. Amato, B. Lecky, E. Choy, I. Lundberg et al., 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, Neuromuscul Disord NMD. mai, vol.14, issue.5, pp.10-12337, 2003.

Y. Troyanov, I. Targoff, J. Tremblay, J. Goulet, R. Y. Senécal et al., Novel Classification of Idiopathic Inflammatory Myopathies Based on Overlap Syndrome Features and Autoantibodies, Medicine, vol.84, issue.4, pp.231-280, 2005.
DOI : 10.1097/01.md.0000173991.74008.b0

A. Meyer, B. Lannes, J. Goetz, A. Echaniz-laguna, D. Lipsker et al., Les nouvelles myopathies inflammatoires, Revue du Rhumatisme, vol.84, issue.5, pp.392-402, 2017.
DOI : 10.1016/j.rhum.2017.01.013

S. Khan and L. Christopher-stine, Polymyositis, Dermatomyositis, and Autoimmune Necrotizing Myopathy: Clinical Features, Rheumatic Disease Clinics of North America, vol.37, issue.2, pp.143-158, 2011.
DOI : 10.1016/j.rdc.2011.01.001

A. Findlay, N. Goyal, and T. Mozaffar, An overview of polymyositis and dermatomyositis, Muscle & Nerve, vol.78, issue.5, pp.638-56, 2015.
DOI : 10.1097/00005792-199905000-00001

M. Kalluri and C. Oddis, Pulmonary Manifestations of the Idiopathic Inflammatory Myopathies, Clinics in Chest Medicine, vol.31, issue.3, pp.501-513, 2010.
DOI : 10.1016/j.ccm.2010.05.008

M. Fathi, I. Lundberg, and G. Tornling, Pulmonary Complications of Polymyositis and Dermatomyositis, Seminars in Respiratory and Critical Care Medicine, vol.28, issue.4, pp.451-459, 2007.
DOI : 10.1055/s-2007-985666

O. Benveniste, W. Stenzel, and Y. Allenbach, Advances in serological diagnostics of inflammatory myopathies, Current Opinion in Neurology, vol.29, issue.5, pp.662-73, 2016.
DOI : 10.1097/WCO.0000000000000376

Y. Ge, X. Lu, X. Shu, Q. Peng, and G. Wang, Clinical characteristics of anti-SAE antibodies in Chinese patients with dermatomyositis in comparison with different patient cohorts. Sci Rep. 15 mars 2017, p.188

L. Zhang, G. Wang, L. Ma, and N. Zu, Cardiac involvement in adult polymyositis or dermatomyositis: a systematic review, Clin Cardiol. nov, vol.35, issue.11, pp.686-91, 2012.

M. Danieli, C. Gelardi, F. Guerra, P. Cardinaletti, V. Pedini et al., Cardiac involvement in polymyositis and dermatomyositis, Autoimmunity Reviews, vol.15, issue.5, pp.462-467
DOI : 10.1016/j.autrev.2016.01.015

C. P. Myosites, Httpwwwem-Premiumcomdocelecu- Bordeauxfrdatatraitestmtm-49767 [Internet]. 16 févr, 2011.

C. Hill, Y. Zhang, B. Sigurgeirsson, E. Pukkala, L. Mellemkjaer et al., Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study, The Lancet, vol.357, issue.9250, pp.96-100, 2001.
DOI : 10.1016/S0140-6736(00)03540-6

R. Buchbinder, A. Forbes, S. Hall, X. Dennett, and G. Giles, Incidence of Malignant Disease in Biopsy-Proven Inflammatory Myopathy: A Population-Based Cohort Study, Annals of Internal Medicine, vol.134, issue.12, pp.1087-95, 2001.
DOI : 10.7326/0003-4819-134-12-200106190-00008

A. Selva-o-'callaghan, E. Trallero-araguás, J. Grau-junyent, and M. Labrador-horrillo, Malignancy and myositis: novel autoantibodies and new insights, Current Opinion in Rheumatology, vol.22, issue.6, pp.627-659, 2010.
DOI : 10.1097/BOR.0b013e32833f1075

I. Lazarou and P. Guerne, Classification, Diagnosis, and Management of Idiopathic Inflammatory Myopathies, The Journal of Rheumatology, vol.40, issue.5, pp.550-64, 2013.
DOI : 10.3899/jrheum.120682

M. Schulze, I. Kötter, U. Ernemann, M. Fenchel, N. Tzaribatchev et al., MRI Findings in Inflammatory Muscle Diseases and Their Noninflammatory Mimics, American Journal of Roentgenology, vol.192, issue.6, pp.1708-1724, 2009.
DOI : 10.2214/AJR.08.1764

E. Adams, C. Chow, A. Premkumar, and P. Plotz, The idiopathic inflammatory myopathies: spectrum of MR imaging findings., RadioGraphics, vol.15, issue.3, pp.563-74, 1995.
DOI : 10.1148/radiographics.15.3.7624563

M. Dalakas, Inflammatory Muscle Diseases, New England Journal of Medicine, vol.372, issue.18, pp.1734-1781, 2015.
DOI : 10.1056/NEJMra1402225

O. Benveniste, O. Dubourg, and S. Herson, Nouvelles classifications et??physiopathologie des??myopathies inflammatoires, La Revue de M??decine Interne, vol.28, issue.9, pp.603-615, 2007.
DOI : 10.1016/j.revmed.2007.03.004

A. Selva-o-'callaghan, J. Grau, C. Gámez-cenzano, A. Vidaller-palacín, X. Martínez-gómez et al., Conventional Cancer Screening versus PET/CT in Dermatomyositis/Polymyositis, The American Journal of Medicine, vol.123, issue.6, pp.558-62, 2010.
DOI : 10.1016/j.amjmed.2009.11.012

M. Fujimoto, R. Watanabe, Y. Ishitsuka, and N. Okiyama, Recent advances in dermatomyositis-specific autoantibodies, Current Opinion in Rheumatology, vol.28, issue.6, pp.636-680, 2016.
DOI : 10.1097/BOR.0000000000000329

Z. Betteridge and N. Mchugh, Myositis-specific autoantibodies: an important tool to support diagnosis of myositis, Journal of Internal Medicine, vol.73, issue.1, pp.8-23, 2016.
DOI : 10.1002/ana.23840

Z. Betteridge, H. Gunawardena, J. North, J. Slinn, and N. Mchugh, Identification of a novel autoantibody directed against small ubiquitin-like modifier activating enzyme in dermatomyositis, Arthritis & Rheumatism, vol.448, issue.9, pp.3132-3139, 2007.
DOI : 10.1097/00005792-199111000-00002

Z. Betteridge, H. Gunawardena, H. Chinoy, J. North, W. Ollier et al., Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis, Annals of the Rheumatic Diseases, vol.68, issue.10, pp.1621-1626, 2009.
DOI : 10.1136/ard.2008.097162

M. Fujimoto, T. Matsushita, Y. Hamaguchi, K. Kaji, Y. Asano et al., Autoantibodies to small ubiquitin-like modifier activating enzymes in Japanese patients with dermatomyositis: comparison with a UK Caucasian cohort, Annals of the Rheumatic Diseases, vol.72, issue.1, pp.151-154, 2013.
DOI : 10.1136/annrheumdis-2012-201736

C. Oddis, Clinical and serological characterization of the anti-MJ antibody in childhood myositis, Arthritis Rheum, vol.40, p.139, 1997.

Y. Ichimura, T. Matsushita, Y. Hamaguchi, K. Kaji, M. Hasegawa et al., Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy, Annals of the Rheumatic Diseases, vol.71, issue.5, pp.710-713, 2012.
DOI : 10.1136/annrheumdis-2011-200697

. Anti-mj, NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis, Arthritis Res Ther, vol.14, issue.2, p.97, 2012.

G. Espada, M. Cocco, J. Fertig, N. Oddis, and C. , Clinical and Serologic Characterization of an Argentine Pediatric Myositis Cohort: Identification of a Novel Autoantibody (anti-MJ) to a 142-kDa Protein, The Journal of Rheumatology, vol.36, issue.11, pp.2547-51, 2009.
DOI : 10.3899/jrheum.090461

H. Gunawardena, L. Wedderburn, H. Chinoy, Z. Betteridge, J. North et al., Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis, Arthritis & Rheumatism, vol.103, issue.6, pp.1807-1821, 2009.
DOI : 10.1056/NEJM197502202920807

S. Tansley, Z. Betteridge, G. Shaddick, H. Gunawardena, K. Arnold et al., Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset, Rheumatology, vol.47, issue.12, pp.2204-2212, 2014.
DOI : 10.1093/rheumatology/ken136

D. Fiorentino, L. Chung, L. Christopher-stine, L. Zaba, S. Li et al., Most Patients With Cancer-Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP-2 or Transcription Intermediary Factor 1??, Arthritis & Rheumatism, vol.146, issue.Suppl, pp.2954-62, 2013.
DOI : 10.1001/archdermatol.2009.328

I. Targoff, G. Mamyrova, E. Trieu, O. Perurena, B. Koneru et al., A novel autoantibody to a 155-kd protein is associated with dermatomyositis, Arthritis & Rheumatism, vol.201, issue.11, pp.3682-3691, 2006.
DOI : 10.1097/00005792-199111000-00002

D. Fiorentino, K. Kuo, L. Chung, L. Zaba, S. Li et al., Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1?? antibodies in adults with dermatomyositis, Journal of the American Academy of Dermatology, vol.72, issue.3, pp.449-55, 2015.
DOI : 10.1016/j.jaad.2014.12.009

K. Hoshino, Y. Muro, K. Sugiura, Y. Tomita, R. Nakashima et al., Anti-MDA5 and anti-TIF1-?? antibodies have clinical significance for patients with dermatomyositis, Rheumatology, vol.60, issue.9, pp.1726-1759, 2010.
DOI : 10.1002/art.24547

K. Kaji, M. Fujimoto, M. Hasegawa, M. Kondo, Y. Saito et al., Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy, Rheumatology, vol.46, issue.1, pp.25-33, 2007.
DOI : 10.1093/rheumatology/kel161

N. Agmon-levin, J. Damoiseaux, C. Kallenberg, U. Sack, T. Witte et al., International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies, Annals of the Rheumatic Diseases, vol.51, issue.1, pp.17-23, 2014.
DOI : 10.1007/978-1-60327-285-8

N. Fabien, Anticorps des myopathies autoimmunes : actualit??s des techniques de d??tection et int??r??t clinique, Revue Francophone des Laboratoires, vol.2016, issue.484, 1073740.
DOI : 10.1016/S1773-035X(16)30243-X

M. Satoh, S. Tanaka, A. Ceribelli, S. Calise, and E. Chan, A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy, Clinical Reviews in Allergy & Immunology, vol.42, issue.Suppl, pp.1-19, 2017.
DOI : 10.1007/s12016-011-8286-7

A. Ghirardello, M. Rampudda, L. Ekholm, N. Bassi, E. Tarricone et al., Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay, Rheumatology, vol.65, issue.12, pp.2370-2374, 2010.
DOI : 10.1136/ard.2006.052191

M. Tampoia, A. Notarnicola, L. Abbracciavento, A. Fontana, M. Giannini et al., A New Immunodot Assay for Multiplex Detection of Autoantibodies in a Cohort of Italian Patients With Idiopathic Inflammatory Myopathies, Journal of Clinical Laboratory Analysis, vol.384, issue.6, pp.859-66, 2016.
DOI : 10.1016/j.jim.2012.07.019

I. Cavazzana, M. Fredi, A. Ceribelli, C. Mordenti, F. Ferrari et al., Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera, Journal of Immunological Methods, vol.433, pp.1-5, 2016.
DOI : 10.1016/j.jim.2016.02.017